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In the recent years the prevalent paradigm in drug dis-
covery of „one drug – one target – one disease“, follow-
ing the assumption that highly selective ligands would
avoid unwandted side effects caused by binding to sec-
onday non-theratpeutic targets, got reconsidered. The
results of post-genomic and network biology showed
that proteins rarely act in isolated systems but rather as
a part of a highly connected network [1]. It was further
shown that the efficacy of several approved drugs is
traced back to the fact that they act on multiple targets
[2]. Therefore inhibiting a single target of such a net-
work might not lead to the desired therapeutic effect.
These findings lead to a shift towards polypharmacology
[3] and the rational design of selective multi-target
drugs, which have often improved efficacy [4]. But the
design of multi target drugs is still a great challenge in
regard of a sufficient activity on each target as well as
an adequate pharmacokinetic profile [5]. Early design
strategies tried to link the pharmacophors of known
inhibitors, however these methods often lead to high
molecular weight and low ligand efficiency.
We present a new approach based on self-organizing
maps [3,6] (SOM) for the identification of multi-target
fragments. We describe a workflow that initially identi-
fies multi-target relevant substructures with a combina-
tion of maximum common substructure search and the
alignment of multiple SOMs. Furthermore, these sub-
structures are trained together with a fragment library
on additional SOMs to find new multi-target fragments,
validated by saturation transfer difference (STD)-NMR
and biochemical assay systems. We used our approach
for the identification of new dual-acting inhibitors of 5-
Lipoxygenase (5-LO) and soluble Epoxide Hydrolase
(sEH), both enzymes located in the arachidonic acid cas-
cade and involved in inflammatory processes, pain and
cadiovascular diseases.
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